Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2015

01.10.2015 | Short Research Report

A retrospective study of cutaneous drug reactions in an outpatient population

verfasst von: Francesco Drago, Ludovica Cogorno, Arianna Fay Agnoletti, Giulia Ciccarese, Aurora Parodi

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background Adverse cutaneous drug reactions (ACDR) are unexpected cutaneous changes occurring at drug dosages that are normally used for disease prophylaxis, diagnosis or treatment. Objective The aim of the study was to determine the clinical types of ACDR, the causative agents, the latency time between drug intake and onset of ACDR and the recovery time in an outpatient population.Method Ninety-five patients diagnosed with ACDR at the Department of Dermatology of the University of Genoa between 2003 and 2012 were retrospectively studied. Results Antimicrobials, especially cephalosporins, were the most responsible for ACDR, followed by non-steroidal anti-inflammatory drugs and antihypertensives. The most common clinical manifestations were exanthema (42.1 %), erythema multiforme (10.53 %) and vasculitis (9.53 %). Patients with peripheral eosinophilia showed a more severe clinical manifestation, they were treated with systemic therapies and their recovery time was longer. Conclusion It is important to have an appropriate clinical approach according to the ACDR severity degree. We think that eosinophilia may characterise severe cutaneous eruptions and that it should always be investigated when ACDR is suspected in order to manage the patient with the appropriate treatment.
Literatur
1.
Zurück zum Zitat Edwards RI, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMed Edwards RI, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMed
2.
Zurück zum Zitat McKenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin North Am. 2004;399–423. McKenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin North Am. 2004;399–423.
3.
Zurück zum Zitat Shear HN, Knowles RS, Sullivan RJ, Shapiro L. Chapter 138, Cutaneous reactions to drugs. Fitzpatrick T, Eisen A, Wolffe K, editors. Dermatology in General Medicine, 8th ed. New York: Mc Graw Hill, p. 1330–1337. Shear HN, Knowles RS, Sullivan RJ, Shapiro L. Chapter 138, Cutaneous reactions to drugs. Fitzpatrick T, Eisen A, Wolffe K, editors. Dermatology in General Medicine, 8th ed. New York: Mc Graw Hill, p. 1330–1337.
4.
Zurück zum Zitat Akpinar F, Dervis E. Drug eruptions: an 8-year study including 106 inpatients at a dermatology clinic in Turkey. Indian J Dermatol. 2012;57:194–8.PubMedCentralCrossRefPubMed Akpinar F, Dervis E. Drug eruptions: an 8-year study including 106 inpatients at a dermatology clinic in Turkey. Indian J Dermatol. 2012;57:194–8.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Zaraa I, Jones M, Trojjet S, Cheikh Rouhou R, El Euch D, Mokni M, et al. Severe adverse cutaneous drug eruptions: epidemiological and clinical features. Int J Dermatol. 2011;50:877–80.CrossRefPubMed Zaraa I, Jones M, Trojjet S, Cheikh Rouhou R, El Euch D, Mokni M, et al. Severe adverse cutaneous drug eruptions: epidemiological and clinical features. Int J Dermatol. 2011;50:877–80.CrossRefPubMed
6.
Zurück zum Zitat Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2000;53:357–79. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2000;53:357–79.
7.
Zurück zum Zitat Apaydin R, Bilen N, Dökmeci S, Bayramgürler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. Eur Acad Dermatol Venereol. 2000;14:518–20.CrossRef Apaydin R, Bilen N, Dökmeci S, Bayramgürler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. Eur Acad Dermatol Venereol. 2000;14:518–20.CrossRef
9.
Zurück zum Zitat Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000;115:149–53.CrossRefPubMed Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000;115:149–53.CrossRefPubMed
Metadaten
Titel
A retrospective study of cutaneous drug reactions in an outpatient population
verfasst von
Francesco Drago
Ludovica Cogorno
Arianna Fay Agnoletti
Giulia Ciccarese
Aurora Parodi
Publikationsdatum
01.10.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0134-z

Weitere Artikel der Ausgabe 5/2015

International Journal of Clinical Pharmacy 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.